Evidence map›Paper›PMID 32874747›Full record

ArticleThe Journal of innovations in cardiac rhythm management2020

Engaging Patients in Atrial Fibrillation Management via Digital Health Technology: The Impact of Tailored Messaging.

Tammy Toscos, Amanda Coupe, Shauna Wagner, Ryan Ahmed, Amelia Roebuck, Mindy Flanagan, Michelle Drouin, Michael Mirro

Open access · diamondAbstract read
In one paragraph

Article in The Journal of innovations in cardiac rhythm management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tammy ToscosParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Amanda CoupeParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Shauna WagnerParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Ryan AhmedParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Amelia RoebuckParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Mindy FlanaganParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Michelle DrouinParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Michael MirroParkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA.
Parkview Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with atrial fibrillation (AF) demonstrate persistent knowledge gaps regarding their condition and a substandard adherence to oral anticoagulant (OAC) medication, which contribute to thromboembolic stroke and other clot-related complications. Tailored patient education and medication reminders may help reduce these negative health outcomes. We sought to improve disease knowledge and medication adherence among a sample of AF patients using tailored education and nudges. The intervention leveraged three digital health technologies: a patient portal, an electronic-prescribing data feed, and a smart pill bottle. The content of the educational messaging, nudges, and cadence were tailored according to findings from our user-centered design studies and delivered via a patient portal (MyChart®; Epic Systems, Verona, WI, USA), with which participants were familiar. In a six-month randomized controlled trial with parallel groups, we used MyChart® to send educational messages and medication reminders according to a decision tree that emerged from our prior user-centered design studies. The intervention group demonstrated higher AF knowledge at study completion than the control group and more MyChart® logins throughout the trial, suggesting intervention uptake. Women were more adherent than men and patients diagnosed more than one year ago were more adherent than those with more recent diagnoses. The intervention and control group adherence rates were 93.1% and 89.5%, respectively; intervention effect was moderated by age, medication type, and prior MyChart® use. Within the intervention group, younger patients, those taking once-daily rivaroxaban, and those who were less active MyChart® users prior to the study benefited relative to their control group counterparts. Tailored educational and reminder messages contributed to increased adherence and disease knowledge among AF patients, though certain patient characteristics moderated the intervention's effectiveness. Technology-based health interventions can be useful for older adults with effective tailoring and training.

Indexed as

Atrial fibrillationconsumer health informaticsdigital healthmedication adherencetailored messaging

Identifiers

PMID32874747
PMCPMC7452738
OpenAlexW3082513019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.